Phase 1 Trial Data Support Safety, Efficacy of Novel Hepatitis B Treatment
Investigators assessed the safety profile and antiviral activity of the agent RO7049389 for the treatment of chronic hepatitis B virus infection.
Hepatitis B
HBV Suppression Lowers Liver Cancer Rates in Patients Coinfected With HIV
Findings emphasize the importance of strategies to help HBV-HIV coinfected patients maximize antiretroviral adherence to achieve hepatitis B viral suppression.
HBV Infection Not Linked to Liver Injury, Mortality in COVID-19
Patients with current or past HBV infection are not at greater risk for liver injury or mortality during COVID-19 infection.
Besifovir Dipivoxil Maleate Effective, Safe for Long-Term Treatment of Chronic Hepatitis B
Study data supports the long-term efficacy and safety of besifovir dipivoxil maleate (BSV) for the treatment of chronic hepatitis B (CHB).
USPSTF Recommends Hep B Screening for Those at Increased Risk
The U.S. Preventive Services Task Force (USPSTF) recommends screening adolescents and adults at increased risk for hepatitis B virus (HBV) infection.
Hepatitis B Exposure Risk, Prevalence in the US Adult Homeless Population
Hepatitis B virus prevalence was 7 to 10 times higher in a homeless population of Los Angeles compared to the general population of the United States.
Hepatocellular Carcinoma Prediction Beyond Year 5 of Therapy in Chronic Hepatitis B
A study identifies risk factors for hepatocellular carcinoma (HCC) after the first 5 years of receiving antiviral therapy in white patients with chronic hepatitis B.
Mother‐to‐Child Transmission Risk in Pregnant Women With Chronic HBV
Front-line providers minimally could check HBV DNA and ALT during pregnancy to assess mother‐to‐child transmission risk but HBeAg is recommended to be included in the initial HBV evaluation to get a more comprehensive understanding of the patient’s HBV disease state.
Weight Loss Normalizes ALT and Improves Long-Term Outcomes in Chronic Hepatitis B
Because after hepatitis B viral suppression the cause and intervention for elevated alanine aminotransferase is somewhat unknown, investigators conducted a real-world study.
Conflict-Driven Migration Increases Hepatitis Burden as Production Costs Fall
Researchers of studies on the effect of conflict-driven migration on rates of hepatitis indicate that mass migration from high-burden countries has significantly increased the prevalence of both hepatitis C virus (HCV) and hepatitis B virus (HBV) infection in the host nation.
- Loading...
Loading...
Next post in Hepatitis
Loading... 
Loading...